Dr Leo Pantilla Pajarillo, MD | |
186 E 2nd Ave Ste 100, Williamson, WV 25661-3602 | |
(304) 236-5902 | |
Not Available |
Full Name | Dr Leo Pantilla Pajarillo |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 186 E 2nd Ave Ste 100, Williamson, West Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497971212 | NPI | - | NPPES |
64698426 | Medicaid | KY | |
0112030000 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 11772 (West Virginia) | Primary |
Entity Name | Williamson Health & Wellness Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467711150 PECOS PAC ID: 5395972996 Enrollment ID: O20140521000620 |
News Archive
New research shows that older Americans with cirrhosis have significantly worse health status and greater functional disability compared to those without this potentially deadly disease. In fact, findings now published in Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases, show that elderly patients with cirrhosis require twice the amount of informal caregiving and contribute added strain on the health care system. Given the increase in obesity and aging of those with hepatitis C (HCV), researchers expect the prevalence of cirrhosis to climb in this frail population.
Australian scientists have made a breakthrough which could help in the fight against cancer. The team from Peter MacCallum Cancer Centre in Melbourne has found a link between non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin, and the ability of tumours to spread in the body. They say that doctors have been aware of the benefits of NSAIDs for many years, but did not fully understand the biological processes involved.
Ethnic and racial minorities bear a disproportionate share of America's diabetes epidemic but are significantly less likely than whites to receive a commonly used test to monitor control of blood glucose, according to Washington State University researchers.
Scientists at A*STAR's Institute of Medical Biology and Institute of Molecular and Cellular Biology have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases. The hormone - which they have chosen to name ELABELA - is only 32 amino-acids long, making it amongst the tiniest proteins made by the human body.
The National Institute for Health and Care Excellence has recommended a new treatment to help patients suffering from blood clots in the legs and lungs.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Leo Pantilla Pajarillo, MD Po Box 2080, Williamson, WV 25661-2080 Ph: (304) 236-5902 | Dr Leo Pantilla Pajarillo, MD 186 E 2nd Ave Ste 100, Williamson, WV 25661-3602 Ph: (304) 236-5902 |
News Archive
New research shows that older Americans with cirrhosis have significantly worse health status and greater functional disability compared to those without this potentially deadly disease. In fact, findings now published in Hepatology, a peer-reviewed journal of the American Association for the Study of Liver Diseases, show that elderly patients with cirrhosis require twice the amount of informal caregiving and contribute added strain on the health care system. Given the increase in obesity and aging of those with hepatitis C (HCV), researchers expect the prevalence of cirrhosis to climb in this frail population.
Australian scientists have made a breakthrough which could help in the fight against cancer. The team from Peter MacCallum Cancer Centre in Melbourne has found a link between non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin, and the ability of tumours to spread in the body. They say that doctors have been aware of the benefits of NSAIDs for many years, but did not fully understand the biological processes involved.
Ethnic and racial minorities bear a disproportionate share of America's diabetes epidemic but are significantly less likely than whites to receive a commonly used test to monitor control of blood glucose, according to Washington State University researchers.
Scientists at A*STAR's Institute of Medical Biology and Institute of Molecular and Cellular Biology have identified a gene encoding a hormone that could potentially be used as a therapeutic molecule to treat heart diseases. The hormone - which they have chosen to name ELABELA - is only 32 amino-acids long, making it amongst the tiniest proteins made by the human body.
The National Institute for Health and Care Excellence has recommended a new treatment to help patients suffering from blood clots in the legs and lungs.
› Verified 2 days ago